1. WHO. World Health Organization. World malaria report 2020. Geneva: World Health Organization; 2020 [cited 2021 September 13]. Available from: https://www.who.int/publications/i/item/9789240015791.
2. WHO. World Health Organization. A global strategy for malaria control, 1993. Geneva: World Health Organization; 1993 [cited 2021 September 13]. Available from: https://apps.who.int/iris/bitstream/handle/10665/41785/9241561610.pdf?sequence=1&isAllowed=y.
3. WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the Treatment of Malaria. Geneva: World Health Organization Copyright © World Health Organization, 2010.; 2010.
4. Maltha J, Gillet P, Jacobs J. Malaria rapid diagnostic tests in travel medicine. Clin Microbiol Infect. 2013;19(5):408-15.
5. McKenzie FE, Sirichaisinthop J, Miller RS, Gasser RA, Jr., Wongsrichanalai C. Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am J Trop Med Hyg. 2003;69(4):372-6.
6. Stow NW, Torrens JK, Walker J. An assessment of the accuracy of clinical diagnosis, local microscopy and a rapid immunochromatographic card test in comparison with expert microscopy in the diagnosis of malaria in rural Kenya. Trans R Soc Trop Med Hyg. 1999;93(5):519-20.
7. Maguire JD, Lederman ER, Barcus MJ, O'Meara WA, Jordon RG, Duong S, et al. Production and validation of durable, high quality standardized malaria microscopy slides for teaching, testing and quality assurance during an era of declining diagnostic proficiency. Malar J. 2006;5:92.
8. Kilian AH, Metzger WG, Mutschelknauss EJ, Kabagambe G, Langi P, Korte R, et al. Reliability of malaria microscopy in epidemiological studies: results of quality control. Trop Med Int Health. 2000;5(1):3-8.
9. Muhindo HM, Ilombe G, Meya R, Mitashi PM, Kutekemeni A, Gasigwa D, et al. Accuracy of malaria rapid diagnosis test Optimal-IT(®) in Kinshasa, the Democratic Republic of Congo. Malar J. 2012;11:224.
10. Mwingira F, Genton B, Kabanywanyi AN, Felger I. Comparison of detection methods to estimate asexual Plasmodium falciparum parasite prevalence and gametocyte carriage in a community survey in Tanzania. Malar J. 2014;13:433.
11. Amoah LE, Abankwa J, Oppong A. Plasmodium falciparum histidine rich protein-2 diversity and the implications for PfHRP 2: based malaria rapid diagnostic tests in Ghana. Malar J. 2016;15:101.
12. Maltha J, Gillet P, Bottieau E, Cnops L, van Esbroeck M, Jacobs J. Evaluation of a rapid diagnostic test (CareStart Malaria HRP-2/pLDH (Pf/pan) Combo Test) for the diagnosis of malaria in a reference setting. Malar J. 2010;9:171.
13. Rozelle JW, Korvah J, Wiah O, Kraemer J, Hirschhorn LR, Price MR, et al. Improvements in malaria testing and treatment after a national community health worker program in rural Liberia. Journal of Global Health Reports. 2021;5:e2021073.
14. Wurtz N, Fall B, Bui K, Pascual A, Fall M, Camara C, et al. Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests. Malar J. 2013;12:34.
15. WHO. World Health Organization. World malaria report 2019. Geneva: World Health Organization; 2019 [cited 2021 September 13]. Available from: https://www.who.int/publications/i/item/9789241565721.
16. WHO. World Health Organization. Malaria Rapid Diagnostic Test Performance. Results of WHO product testing of RDTs: Round 8 (2016-2018) Geneva: World Health Organization; 2018 [cited 2021 November 3]. Available from: https://apps.who.int/iris/bitstream/handle/10665/276190/9789241514965-eng.pdf.
17. WHO. World Health Organization. P. falciparum hrp2/3 gene deletions: conclusions and recommendations of a technical consultation Geneva: World Health Organization; 2016 [cited 2021 September 13]. Available from: https://www.who.int/malaria/mpac/mpac-sept2016-hrp2-consultation-short-report-session7.pdf.
18. Chiodini PL, Bowers K, Jorgensen P, Barnwell JW, Grady KK, Luchavez J, et al. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans R Soc Trop Med Hyg. 2007;101(4):331-7.
19. Lee N, Gatton ML, Pelecanos A, Bubb M, Gonzalez I, Bell D, et al. Identification of optimal epitopes for Plasmodium falciparum rapid diagnostic tests that target histidine-rich proteins 2 and 3. J Clin Microbiol. 2012;50(4):1397-405.
20. Lee N, Baker J, Andrews KT, Gatton ML, Bell D, Cheng Q, et al. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. J Clin Microbiol. 2006;44(8):2773-8.
21. WHO. World Health Organization. Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: Round 5 (2013). Geneva: World Health Organization; 2013 [cited 2021 September 4]. Available from: https://www.who.int/publications/i/item/9789241507554.
22. Parr JB, Verity R, Doctor SM, Janko M, Carey-Ewend K, Turman BJ, et al. Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey. J Infect Dis. 2017;216(1):36-44.
23. Parr JB, Kieto E, Phanzu F, Mansiangi P, Mwandagalirwa K, Mvuama N, et al. Analysis of false-negative rapid diagnostic tests for symptomatic malaria in the Democratic Republic of the Congo. Sci Rep. 2021;11(1):6495.
24. Munyeku YB, Musaka AA, Ernest M, Smith C, Mansiangi PM, Culleton R. Prevalence of Plasmodium falciparum isolates lacking the histidine rich protein 2 gene among symptomatic malaria patients in Kwilu Province of the Democratic Republic of Congo. Infect Dis Poverty. 2021;10(1):77.
25. Nundu SS, Culleton R, Simpson SV, Arima H, Muyembe JJ, Mita T, et al. Malaria parasite species composition of Plasmodium infections among asymptomatic and symptomatic school-age children in rural and urban areas of Kinshasa, Democratic Republic of Congo. Malar J. 2021;20(1):389.
26. Parr JB, Anderson O, Juliano JJ, Meshnick SR. Streamlined, PCR-based testing for pfhrp2- and pfhrp3-negative Plasmodium falciparum. Malar J. 2018;17(1):137.
27. WHO. World Health Organization. False-negative RDT results and implications of new P. falciparum histidine-rich protein 2/3 gene deletions, 2016. Geneva: World Health Organization; 2016 [cited 2021 Septemeber 16]. Available from: https://apps.who.int/iris/bitstream/handle/10665/258972/WHO-HTM-GMP-2017.18-eng.pdf;jsessionid=BA37E3E369DFA1098EAA29E4938FF6C3?sequence=1.
28. WHO. World Health Organization. Response plan to pfhrp2 gene deletions, 2019. Geneva: World Health Organization; 2019 [cited 2021 September 16]. Available from: https://apps.who.int/iris/bitstream/handle/10665/325528/WHO-CDS-GMP-2019.02-eng.pdf.
29. Parr JB, Meshnick SR. Response to Woodrow and Fanello. J Infect Dis. 2017;216(4):503-4.
30. Woodrow CJ, Fanello C. Pfhrp2 Deletions in the Democratic Republic of Congo: Evidence of Absence, or Absence of Evidence? J Infect Dis. 2017;216(4):504-6.
31. Berhane A, Anderson K, Mihreteab S, Gresty K, Rogier E, Mohamed S, et al. Major Threat to Malaria Control Programs by Plasmodium falciparum Lacking Histidine-Rich Protein 2, Eritrea. Emerg Infect Dis. 2018;24(3):462-70.
32. WHO. World Health Organization. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions, 2017. Geneva: World Health Organization; 2017 [cited 2021 September 16]. Available from: https://apps.who.int/iris/bitstream/handle/10665/258972/WHO-HTM-GMP-2017.18-eng.pdf;jsessionid=BA37E3E369DFA1098EAA29E4938FF6C3?sequence=1.
33. Watson OJ, Sumner KM, Janko M, Goel V, Winskill P, Slater HC, et al. False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa. BMJ Glob Health. 2019;4(4):e001582.
34. Wu L, van den Hoogen LL, Slater H, Walker PG, Ghani AC, Drakeley CJ, et al. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies. Nature. 2015;528(7580):S86-93.
35. Ho MF, Baker J, Lee N, Luchavez J, Ariey F, Nhem S, et al. Circulating antibodies against Plasmodium falciparum histidine-rich proteins 2 interfere with antigen detection by rapid diagnostic tests. Malar J. 2014;13:480.
36. Pasquier G, Azoury V, Sasso M, Laroche L, Varlet-Marie E, Houzé S, et al. Rapid diagnostic tests failing to detect infections by Plasmodium falciparum encoding pfhrp2 and pfhrp3 genes in a non-endemic setting. Malar J. 2020;19(1):179.
37. Lo E, Zhou G, Oo W, Afrane Y, Githeko A, Yan G. Low parasitemia in submicroscopic infections significantly impacts malaria diagnostic sensitivity in the highlands of Western Kenya. PLoS One. 2015;10(3):e0121763.
38. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58(2):283-92.
39. Zaw MT, Thant M, Hlaing TM, Aung NZ, Thu M, Phumchuea K, et al. Asymptomatic and sub-microscopic malaria infection in Kayah State, eastern Myanmar. Malar J. 2017;16(1):138.
40. Zainabadi K. Ultrasensitive Diagnostics for Low-Density Asymptomatic Plasmodium falciparum Infections in Low-Transmission Settings. J Clin Microbiol. 2021;59(4).
41. Doctor SM, Liu Y, Anderson OG, Whitesell AN, Mwandagalirwa MK, Muwonga J, et al. Low prevalence of Plasmodium malariae and Plasmodium ovale mono-infections among children in the Democratic Republic of the Congo: a population-based, cross-sectional study. Malar J. 2016;15:350.